🇺🇸 FDA
Patent

US 7601718

Compositions useful as inhibitors of protein kinases

granted A61PA61P25/28A61P3/10

Quick answer

US patent 7601718 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61P, A61P25/28, A61P3/10